Transcatheter aortic valve implantation and its impact on mitral valve geometry and function.


Journal

Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 31 03 2020
revised: 07 05 2020
accepted: 07 05 2020
pubmed: 12 7 2020
medline: 15 5 2021
entrez: 12 7 2020
Statut: ppublish

Résumé

The aim of this study was to evaluate the impact of transcatheter aortic valve implantation (TAVI) on mitral valve geometry and function. Eighty-four patients underwent TAVI. Forty-four (52%) patients received a balloon-expandable valve and 40 (48%) were implanted with a self-expandable valve. All patients underwent three-dimensional-volumetric transesophageal echocardiography of the mitral valve before and immediately after TAVI. A dedicated software was used for assisted semiautomatic measurement of mitral annular geometry. During systole, the anterior to posterior (AP) diameter was significantly reduced after the procedure (3.4 ± 0.5 cm vs 3.2 ± 0.5 cm; P < .05). The mitral annular area (10.8 ± 2.8cm TAVI significantly impacts the mitral valve and mitral annular geometry and morphology. The choice of the prosthesis (balloon- vs self-expandable) may be relevant for those changes.

Sections du résumé

BACKGROUND BACKGROUND
The aim of this study was to evaluate the impact of transcatheter aortic valve implantation (TAVI) on mitral valve geometry and function.
METHODS METHODS
Eighty-four patients underwent TAVI. Forty-four (52%) patients received a balloon-expandable valve and 40 (48%) were implanted with a self-expandable valve. All patients underwent three-dimensional-volumetric transesophageal echocardiography of the mitral valve before and immediately after TAVI. A dedicated software was used for assisted semiautomatic measurement of mitral annular geometry.
RESULTS RESULTS
During systole, the anterior to posterior (AP) diameter was significantly reduced after the procedure (3.4 ± 0.5 cm vs 3.2 ± 0.5 cm; P < .05). The mitral annular area (10.8 ± 2.8cm
CONCLUSION CONCLUSIONS
TAVI significantly impacts the mitral valve and mitral annular geometry and morphology. The choice of the prosthesis (balloon- vs self-expandable) may be relevant for those changes.

Identifiants

pubmed: 32652711
doi: 10.1111/jocs.14734
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2185-2193

Informations de copyright

© 2020 The Authors. Journal of Cardiac Surgery published by Wiley Periodicals LLC.

Références

Unger P, Dedobbeleer C, van Camp G, Plein D, Cosyns B, Lancellotti P. Republished review: Mitral regurgitation in patients with aortic stenosis undergoing valve replacement. Postgrad Med J. 2011;87(1024):150-155.
Toggweiler S, Boone RH, Rodés-Cabau J, et al. Transcatheter aortic valve replacement: outcomes of patients with moderate or severe mitral regurgitation. J Am Coll Cardiol. 2012;59(23):2068-2074.
Mavromatis K, Thourani VH, Stebbins A, et al. Transcatheter aortic valve replacement in patients with aortic stenosis and mitral regurgitation. Ann Thorac Surg. 2017;104(6):1977-1985.
Barbanti M, Webb JG, Hahn RT, et al. Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A. Circulation. 2013;128(25):2776-2784.
Tassan-Mangina S, Metz D, Nazeyrollas P, et al. Factors determining early improvement in mitral regurgitation after aortic valve replacement for aortic valve stenosis: a transthioracic and transesophageal prospective study. Clin Cardiol. 2003;26(3):127-131. https://doi.org/10.1002/clc.4960260306
Lin Q-S, Fang F, Yu C-M, et al. Dynamic assessment of the changing geometry of the mitral apparatus in 3D could stratify abnormalities in functional mitral regurgitation and potentially guide therapy. Int J Cardiol. 2014;176(3):878-884.
Mahmood F, Warraich HJ, Gorman JH 3rd, et al. Changes in mitral annular geometry after aortic valve replacement: a three-dimensional transesophageal echocardiographic study. J Heart Valve Dis. 2012;21(6):696-701.
Warraich HJ, Matyal R, Bergman R, et al. Impact of aortic valve replacement for aortic stenosis on dynamic mitral annular motion and geometry. Am J Cardiol. 2013;112(9):1445-1449.
Shibayama K, Harada K, Berdejo J, et al. Effect of transcatheter aortic valve replacement on the mitral valve apparatus and mitral regurgitation: real-time three-dimensional transesophageal echocardiography study. Circ Cardiovasc Imaging. 2014;7(2):344-351.
Vergnat M, Levack MM, Jackson BM, et al. The effect of surgical and transcatheter aortic valve replacement on mitral annular anatomy. Ann Thorac Surg. 2013;95(2):614-619.
Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33(19):2451-2496.
Lancellotti P, Moura L, Pierard LA, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr. 2010;11(4):307-332.
Mihăilă S, Muraru D, Piasentini E, et al. Quantitative analysis of mitral annular geometry and function in healthy volunteers using transthoracic three-dimensional echocardiography. J Am Soc Echocardiogr. 2014;27(8):846-857.
Wickham H, Grolemund G. R for Data Science: Import, Tidy, Transform, Visualize, and Model Data. Farnham, UK: O'Reilly Media, Inc; 2016.
Khabbaz KR, Mahmood F, Shakil O, et al. Dynamic 3-dimensional echocardiographic assessment of mitral annular geometry in patients with functional mitral regurgitation. Ann Thorac Surg. 2013;95(1):105-110.
Bartels K, Thiele RH, Phillips-Bute B, et al. Dynamic indices of mitral valve function using perioperative three-dimensional transesophageal echocardiography. J Cardiothorac Vasc Anesth. 2014;28(1):18-24.
Nombela-Franco L, Eltchaninoff H, Zahn R, et al. Clinical impact and evolution of mitral regurgitation following transcatheter aortic valve replacement: a meta-analysis. Heart. 2015;101(17):1395-1405.
Itabashi Y, Shibayama K, Mihara H, et al. Significant reduction in mitral regurgitation volume is the main contributor for increase in systolic forward flow in patients with functional mitral regurgitation after transcatheter aortic valve replacement: hemodynamic analysis using echocardiography. Echocardiography. 2015;32(11):1621-1627.
Hekimian G, Detaint D, Messika-Zeitoun D, et al. Mitral regurgitation in patients referred for transcatheter aortic valve implantation using the Edwards Sapien prosthesis: mechanisms and early postprocedural changes. J Am Soc Echocardiogr. 2012;25(2):160-165.

Auteurs

Alexander Meyer (A)

Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.
Berlin Institute of Health, Berlin, Germany.
DZHK (German Center for Cardiovascular Research), partner site Berlin, Berlin, Germany.

Dustin Greve (D)

Department of Cardiovascular Surgery, Berlin Institute of Health, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlinand, Berlin, Germany.

Axel Unbehaun (A)

Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.
DZHK (German Center for Cardiovascular Research), partner site Berlin, Berlin, Germany.

Markus Kofler (M)

Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.

Marian Kukucka (M)

Institute of Anesthesiology, German Heart Center Berlin, Berlin, Germany.

Christoph Klein (C)

Department of Cardiology, German Heart Center Berlin, Berlin, Germany.

Jan Knierim (J)

Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.

Maximilian Y Emmert (MY)

Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.
Department of Cardiovascular Surgery, Berlin Institute of Health, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlinand, Berlin, Germany.

Volkmar Falk (V)

Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.
DZHK (German Center for Cardiovascular Research), partner site Berlin, Berlin, Germany.
Department of Cardiovascular Surgery, Berlin Institute of Health, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlinand, Berlin, Germany.
Department of Health Science Technology, Swiss Federal Institute of Technology, Zurich, Switzerland.

Jörg Kempfert (J)

Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.
DZHK (German Center for Cardiovascular Research), partner site Berlin, Berlin, Germany.

Simon H Sündermann (SH)

Department of Cardiothoracic and Vascular Surgery, German Heart Center Berlin, Berlin, Germany.
DZHK (German Center for Cardiovascular Research), partner site Berlin, Berlin, Germany.
Department of Cardiovascular Surgery, Berlin Institute of Health, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlinand, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH